Search results
Results from the Tech24 Deals Content Network
Viatris. Viatris (NASDAQ: VTRS) is a global healthcare company formed through the merger of Mylan and Upjohn, ... Moreover, its dividend yield stands at a healthy 2.88%. Ally is also projected to ...
Viatris isn't and might never be a great pick for growth investors. However, I think it's a good choice for income investors, with its forward dividend yield of nearly 4% and an improving outlook.
Mylan N.V. was a global generic and specialty pharmaceuticals company. In November 2020, Mylan merged with Upjohn, Pfizer 's off-patent medicine division, to form Viatris. [ 1] Previously, the company was domiciled in the Netherlands, with principal executive offices in Hatfield, Hertfordshire, UK [ 2] and a "Global Center" in Canonsburg ...
Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn , a legacy division of Pfizer , on November 16, 2020.
Viatris also reaffirmed its full-revenue revenue forecast to the range of $15.5 billion to $16 billion, compared to analysts' estimates of $15.60 billion. Excluding items, the company reported a ...
The S&P 500 Dividend Aristocrats is a stock market index composed of the companies in the S&P 500 index that have increased their dividends in each of the past 25 consecutive years. It was launched in May 2005. [ 1]
Viatris was formed with the merger of Mylan and Pfizer's Upjohn business and has generic and key branded drugs in its portfolio, including erectile dysfunction drug Viagra, anti-anxiety medication ...
For premium support please call: 800-290-4726 more ways to reach us